Inpixon announced that the subscription period for its previously announced rights offering has commenced. If exercising subscription rights through a broker, dealer, bank or other nominee, rights holders should promptly contact their nominee and submit subscription documents and payment for the units subscribed for in accordance with the instructions and within the time period provided by such nominee. The broker, dealer, bank or other nominee may establish a deadline before December 21, by which instructions to exercise subscription rights, along with the required subscription payment, must be received. All record holders of rights that wish to participate in the rights offering must deliver a properly completed and signed subscription rights statement, together with payment of the subscription price for both basic subscription rights and any over subscription privilege election for delivery no later than December 21 to the subscription agent. Under the rights offering, Inpixon will distribute one non-transferable subscription right for each share of common stock, preferred stock and each participating warrant held on the record date, December 6. The subscription rights will be exercisable for up to an aggregate of $10M of units, subject to increase at the discretion of the company, with aggregate participation to be allocated among holders, subject to certain participation rights, on a pro rata basis if in excess of that threshold. Each right will entitle the holder to purchase one unit, at a subscription price of $1,000 per unit, consisting of one share of Series 5 Convertible Preferred Stock with a stated value of $1,000 and 200 warrants to purchase Inpixon's common stock with an exercise price of $5.00 per share. The warrants will be exercisable for 5 years after the date of issuance. Inpixon has applied to list the warrants on the Nasdaq Capital Market, although there is no assurance that a sufficient number of subscription rights will be exercised so that the warrants will meet the minimum listing criteria to be accepted for listing on the Nasdaq Capital Market.
